Transdiagnostic Cognitive Biomarkers
Purpose
The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.
Conditions
- Pain
- Depression
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Have access to the online study platform.
Exclusion Criteria
- under 18, non-English speaking Arm 2: pain and depression: Inclusion Criteria: - Pain or depression Exclusion Criteria: - pregnant women
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Non-Randomized
- Intervention Model
- Single Group Assignment
- Intervention Model Description
- Feasibility study
- Primary Purpose
- Diagnostic
- Masking
- None (Open Label)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Active Comparator Healthy Comparison Group |
Behavioral tasks and surveys online. |
|
Experimental Pain/Depression patients from clinic |
MRI, TMS and EEG, and behavioral tasks and surveys online. |
|
Recruiting Locations
More Details
- Status
- Recruiting
- Sponsor
- University of Minnesota
Detailed Description
This study aims to test the feasibility of procedures aimed at discovering transdiagnostic biomarkers for cognitive impairment in chronic pain and depression. Fifteen healthy control participants and 15 participants from each disease group (chronic pain, depression) will be recruited. Using a task-based fmri, TMS will be targeted for priming of the Left DLPFC. EEG will be used during our behavioral paradigm to compare changes in DLPFC function before and after primed TMS.